This research is being done to pilot an intervention which aims to improve participants' experiences on Endocrine Therapy. The name of the intervention used in this research study is: Endocrine Therapy Education Program (a brief, video-based intervention)
This research study is a randomized pilot study to determine whether a brief-video based intervention program can improve experiences of Endocrine Therapy (ET). Participants will be randomized into one of two groups: Group A: Endocrine Therapy Education Intervention vs. Group B Wait-list Control Group. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, in-clinic visits, and survey questionnaires. Participation in this research study is expected to last 3 months. It is expected that about 60 people will take part in this research study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
76
Brief, video-based intervention program to improve endocrine therapy adherence and experiences and to provide detailed education to participants. The intervention is distributed and assessed via the MyEmma platform, a HIPAA-compliant, online communications platform.
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Engagement Rate of Intervention
Adequate engagement of the intervention is defined as a click-to-open rate of 60% or over for the intervention group.
Time frame: 6 weeks
Intervention Satisfaction Questionnaire Mean Score Group A
Responses will be analyzed to determine a mean score for each item for the intervention group. The Intervention Satisfaction Questionnaire includes 9 items rated on a 1 to 10 scale.
Time frame: At 6 weeks
Intervention Satisfaction Questionnaire Mean Score Group B
Responses will be analyzed to determine a mean score for each item for the control group (following the release of the intervention educational videos). The Intervention Satisfaction Questionnaire includes 9 items rated on a 1 to 10 scale.
Time frame: At 14 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.